Proteomedix is the leading brand in next-generation blood tests for prostate cancer diagnosis. With their innovative Proclarix® test, they offer a non-invasive, fast, and precise method to identify high-grade prostate cancer without the need for risky and painful tissue biopsies. The Proclarix test is easily performed at local laboratories, using the same blood sample as a standard PSA test, providing clear answers to uncertain PSA results.

With the use of Proclarix, patients can gain immediate clarity and relief after their first doctor visit, reducing anxiety and potential time-consuming procedures. For physicians, Proclarix provides clear decision support and improved patient management, while the healthcare system benefits from early rule-outs and fewer complications. Supported by clinical evidence and CE-IVD certification, Proclarix has demonstrated its efficacy in reducing the number of biopsies needed to reliably detect clinically significant prostate cancer.

Proteomedix – providing clarity and peace of mind in prostate cancer diagnosis